Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction
Stella Victorelli(Mayo Clinic in Florida), João F. Passos(Newcastle University), Jodie Birch(Newcastle University), Jeff S. Pawlikowski(Vanderbilt University Medical Center), Diana Jurk(Mayo Clinic in Florida), Duncan Talbot(Unilever (United Kingdom)), James Chapman(Newcastle Hospitals - Campus for Ageing and Vitality), Diana van Heemst(Leiden University Medical Center), Alexander Meves(Mayo Clinic), Jessica Halim(Newcastle Hospitals - Campus for Ageing and Vitality), David A. Gunn(Unilever (United Kingdom)), Marian Beekman(Leiden University Medical Center), Mikołaj Ogrodnik(Austrian Cluster for Tissue Regeneration), P. Eline Slagboom(Universität für Weiterbildung Krems), Anthony B. Lagnado(Mayo Clinic), W.A.L. Moore(Newcastle Hospitals - Campus for Ageing and Vitality), Karen Barrett(University of British Columbia), Peter D. Adams(Discovery Institute)
Cited by 245
Related Papers
Persistent epigenetic differences associated with prenatal exposure to famine in humans
|Proceedings of the National Academy of Sciences|2008|3k
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific
|Human Molecular Genetics|2009|1.1k
Senescence and the SASP: many therapeutic avenues
|Genes & Development|2020|1.1k
Cellular senescence drives age-dependent hepatic steatosis
|Nature Communications|2017|1k